Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
366 |
|
| Actual shortage: | 8 (2%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 5 (1%) | |
| Resolved: | 352 (96%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
51 (14%) |
|
Overdue reports |
3 (33%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2023-10-03 | 2023-11-17 | 205907 |
| FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2024-07-05 | 2024-10-03 | 232398 |
| FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2024-08-23 | 2024-09-19 | 235827 |
| FENTANYL CITRATE INJECTION, USP | 50MCG | SOLUTION | Resolved | 2025-03-13 | 2025-04-15 | 252529 |
| FLUMAZENIL INJECTION, USP | 0.1MG | SOLUTION | Resolved | 2017-09-08 | 2017-11-18 | 21779 |
| FLUMAZENIL INJECTION, USP | 0.1MG | SOLUTION | Resolved | 2019-10-01 | 2020-01-16 | 95165 |
| FLUMAZENIL INJECTION, USP | 0.1MG | SOLUTION | Resolved | 2021-01-06 | 2021-02-10 | 130916 |
| FLUMAZENIL INJECTION, USP | 0.1MG | SOLUTION | Resolved | 2021-08-27 | 2021-11-04 | 144794 |
| FLUMAZENIL INJECTION, USP | 0.1MG | SOLUTION | Resolved | 2021-11-04 | 2022-02-17 | 148857 |
| FOLIC ACID INJECTION, USP | 5MG | SOLUTION | Resolved | 2017-09-15 | 2018-02-01 | 22207 |
| FOLIC ACID INJECTION, USP | 5MG | SOLUTION | Resolved | 2020-03-02 | 2021-01-26 | 107559 |
| FOLIC ACID INJECTION, USP | 5MG | SOLUTION | Resolved | 2021-03-29 | 2021-06-17 | 136531 |
| FOLIC ACID INJECTION, USP | 5MG | SOLUTION | Resolved | 2022-01-17 | 2022-01-20 | 152914 |
| FOLIC ACID INJECTION, USP | 5MG | SOLUTION | Actual shortage | 2025-10-03 | 2025-10-15 | 268583 |
| GANCICLOVIR FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2020-03-02 | 2020-08-06 | 107563 |
| GANCICLOVIR FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2022-06-27 | 2022-07-16 | 163499 |
| HALOPERIDOL INJECTION, USP | 5MG | SOLUTION | Resolved | 2018-01-08 | 2018-03-01 | 35112 |
| HALOPERIDOL INJECTION, USP | 5MG | SOLUTION | Resolved | 2018-05-30 | 2018-08-10 | 50916 |
| HALOPERIDOL INJECTION, USP | 5MG | SOLUTION | Resolved | 2019-04-16 | 2019-07-06 | 81836 |
| HALOPERIDOL INJECTION, USP | 5MG | SOLUTION | Resolved | 2020-02-07 | 2020-04-14 | 105501 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Discontinued | 2024-10-03 | 2024-10-03 | 239180 |
Showing 1 to 2 of 2